N-((5-Bromopyridin-3-yl)methyl)-2-methoxyethanamine

Catalog No. :
ACSEXU243
CAS No. :
1246034-49-0
Molecular Formula :
C9H13BrN2O
Molecular Weight :
245.12

IUPAC Name:N-((5-bromopyridin-3-yl)methyl)-2-methoxyethan-1-amine

N-((5-Bromopyridin-3-yl)methyl)-2-methoxyethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$425.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((5-Bromopyridin-3-yl)methyl)-2-methoxyethanamine
IUPAC NameN-((5-bromopyridin-3-yl)methyl)-2-methoxyethan-1-amine
MDL No.MFCD16793235
Molecular FormulaC9H13BrN2O
Molecular Weight245.12
SMILESCOCCNCC1=CC(Br)=CN=C1
InChI KeyFQABEWNVZMCLPI-UHFFFAOYSA-N
SynonymN-((5-bromopyridin-3-yl)methyl)-2-methoxyethanamine;5-bromo-N-(2-methoxyethyl)-3-Pyridinemethan amine;3-Pyridinemethanamine, 5-bromo-N-(2-methoxyethyl)-;N-((5-bromopyridin-3-yl)methyl)-2-methoxyethan-1-amine
CAS No.1246034-49-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSEXU243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWAKZ917 route compound structure diagram
    ACWAKZ917663941-77-3 In Stock
  2. Plus
  3. ACJPUX285 route compound structure diagram
    ACJPUX28539741-46-3 In Stock
  4. Then
  5. ACSEXU243 route product structure diagram
    ACSEXU2431246034-49-0
Inquiry

2. ACSEXU243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWAKZ917 route compound structure diagram
    ACWAKZ917663941-77-3 In Stock
  2. Plus
  3. ACDQSI627 route compound structure diagram
    ACDQSI627113118-81-3 In Stock
  4. Then
  5. ACSEXU243 route product structure diagram
    ACSEXU2431246034-49-0
Inquiry

Comments (0)